1-3 of 3
Neha Singh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis

James T. Lim, Neha Singh, Libia A. Leuvano, Valerie S. Calvert, Emanuel F. Petricoin, David T. Teachey, Richard B. Lock, Megha Padi, Andrew S. Kraft, Sathish K.R. Padi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (9): 1809–1821.
https://doi.org/10.1158/1535-7163.MCT-20-0160
Published: 02 September 2020
View article titled, PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis
Open the PDF for PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis in another window
Includes: Supplementary data
Journal Articles

Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase

Jin H. Song, Neha Singh, Libia A. Luevano, Sathish K.R. Padi, Koichi Okumura, Virginie Olive, Stephen M. Black, Noel A. Warfel, David W. Goodrich, Andrew S. Kraft
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (12): 2710–2721.
https://doi.org/10.1158/1535-7163.MCT-18-0374
Published: 03 December 2018
View article titled, Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
Open the PDF for Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase in another window
Includes: Supplementary data
Journal Articles

Abstract A293: Novel allosteric small molecule FAK inhibitors effectively inhibit cancer cell viability and clonogenicity.

Vita M. Golubovskaya, Iryna Lebedyeva, Baotran Ho, Michael Yemma, Neha Singh, Makayla Arcara, David Ostrov, Alan Katritzky, William Cance
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A293.
https://doi.org/10.1158/1535-7163.TARG-13-A293
Published: 01 November 2013
View article titled, Abstract A293: Novel allosteric small molecule FAK inhibitors effectively inhibit cancer cell viability and clonogenicity.